Treatment & Services
- Adult Rheumatology
- Aorta Center
- Bone Density Testing
- Clinical Trials
- Infusions Of Biologic Agents On Site
- Joint Aspiration
- Joint Injections
Specialty in Diseases & Conditions
- Giant Cell Arteritis
- Microscopic Polyangiitis (MPA)
- Polyarteritis Nodosa
- Takayasu's Arteritis
- Wegener's Granulomatosis
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.View All Plans
Education & Professional Highlights
Education & Fellowships
Graduate - Duke University
Durham, NC USA
Fellowship - Duke University Medical Center
Durham, NC USA
Residency - University of Michigan Health System
Ann Arbor, MI USA
Internship - University of Michigan Health System
Ann Arbor, MI USA
Medical School - University of California-Los Angeles School of Medicine
Los Angeles, CA USA
Undergraduate - University of California-Riverside
Riverside, CA USA
- Master of Health Sciences, Duke University, 1995
- Harold C. Schott Endowed Chair in Rheumatic and Immunologic Diseases, 2011-Present
- Research Contract Award, NIAMS, National Institutes of Health, 2007-2015, Principal Investigator for a study entitled “Concurrent Pilot Studies in Giant Cell Arteritis (GCA) and Takayasu’s arteritis (TAK) to Examine the Safety, Efficacy, and Immunologic Effects of Abatacept (CTLA4-Ig) in Large Vessel Vasculitis.”
- Director, Center for Vasculitis Care and Research, Cleveland Clinic, 2004-Present
- Vice-Chair, Rheumatology for Research, Cleveland Clinic, 2007-Present
- Senior Investigator, NIAID, National Institutes of Health, 1994-2004
- Chair, Institutional Review Board, NIAID, National Institutes of Health, 1999-2002
- Internal Medicine - Rheumatology
Awards & Honors
- Harold C. Schott Endowed Chair, 2011-Present
- Top Docs in Cleveland, Cleveland magazine, 2006-2014
- NIAID Staff Recognition Award, 1998-2004
- NIAID Special Act of Service Award, 2001
- UCLA Honors in Internal Medicine, 1987
- Phi Beta Kappa, 1984
- American College of Physicians
- American College of Rheumatology
Research & Publications
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/1/2016, Dr. Langford has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Consulting and/or Speaking. Dr. Langford receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:
- American College of Rheumatology
- Focus Medical Communications
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
89 Patient Satisfaction Reviews
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.
|Courtesy, Respect & Concern||5|
|Knows Medical History||5|
|Time Spent with Patient||5|
|Patient Rating of Doctor||5|
6 Patient Comments
Reviewed on Mar 7, 2017
Dr. Langford provides outstanding care. She listens to issues, and includes my input in decisions for care and treatment.
Reviewed on Dec 7, 2016
My case is very complex, but Dr. Langford always leaves me feeling that there is hope for a normal life.
Reviewed on Nov 8, 2016
I feel VERY FORTUNATE to be a patient of Dr. Langford & the Cleveland Clinic!
Reviewed on Oct 25, 2016
My disease is extraordinarily rare and complicated. As a physician myself, I know how difficult treatment must be. I have been to the very best and most excellent physicians in California for treatment. Still, I rely on the advice of Dr. Langford. It was a busy day for Dr. Langford, and I could see her walking quickly from room to room as she efficiently addressed the healthcare needs of her patients. Yet, she was patient with me and allowed me to explain my concerns. Dr. Langford is the best, the kindest and the most thorough physician I have ever had the privilege to meet.
Reviewed on Sep 14, 2016
Dr. LAngford takes care of her patient really well!
Reviewed on May 24, 2016
yes she did take time to inform me of how my treatment on chemo will go when I flare again
© 2017 The Cleveland Clinic Foundation. All Rights Reserved. No part of this work may be altered, reproduced, stored in a retrieval system, or transmitted, in any form, by any means, whether electronic, mechanical, by photocopying, recording, or otherwise, without the prior written permission of the Cleveland Clinic.